QUESTIONS? Text: (855) 436-5457 or Call (719) 266-5800 MST support@amazing-meds.com

A pellet crash is the predictable drop in hormone levels as testosterone or estradiol pellets deplete. It commonly happens around week 10 because hormone output declines before the scheduled reinsertion window. The most effective response is to confirm your levels and adjust your treatment—not to wait it out.

Medically reviewed by Dr. Frangos, MD — board-certified physician with experience in hormone optimization.


If you’ve been on pellet therapy, you may have noticed a pattern.

You feel stable for a while. Energy improves, sleep gets better, and symptoms settle.

Then, often without warning, something shifts.

Fatigue returns. Mood changes. Sleep becomes inconsistent again.

This is not random, and it is not something you are imagining.

It is what’s known as a pellet crash, and it follows a predictable physiological pattern.


What a pellet crash actually is

A pellet crash occurs when hormone levels fall below the range needed to maintain symptom control.

Pellets release hormones continuously after insertion, but that release is not constant. Over time, output declines as the pellet dissolves.

By the later part of the cycle, many patients reach a point where hormone levels are no longer sufficient to support how they felt earlier.

At that point, symptoms return.


Why it often happens around week 10

Patients are usually told that pellets last 12 to 16 weeks.

In practice, many experience symptom return earlier.

This happens because the actual rate of hormone depletion varies between individuals.

Several factors influence how quickly a pellet dissolves:

    • physical activity level
    • metabolic rate
    • body composition
    • pellet size and formulation

Because of these variables, the scheduled reinsertion window does not always match your body’s actual timeline.

For many patients, that mismatch becomes noticeable around week 10.


What the typical pellet cycle looks like

Phase Timeline What Happens
Early phase Weeks 1–4 Hormone levels peak, sometimes above normal
Mid phase Weeks 4–8 Symptoms are well controlled
Decline phase Weeks 8–12 Hormone levels begin to fall
Trough phase Weeks 10–16 Symptoms return as levels drop

The crash is not a complication. It reflects how pellet delivery works pharmacologically.


Why the change feels sudden

Many patients describe the crash as abrupt.

They feel fine one week, and noticeably worse the next.

This happens because symptom response does not decline gradually in the same way hormone levels do.

There is usually a threshold. Once hormone levels drop below that threshold, symptoms reappear quickly.


What your labs would show during a crash

If you test your hormone levels during this phase, results typically confirm your symptoms.

Lab Marker Expected Finding
Total testosterone Low or low-normal
Free testosterone Reduced
Estradiol (for women) Declining

Lab confirmation helps guide the next step in treatment.


What to do if you are currently crashing

The most important step is to act early.

Start by contacting your provider and requesting lab work. A standard hormone panel is usually enough.

If levels are low, ask about short-term options to stabilize your hormones.

Option Purpose
Testosterone gel Short-term symptom support
Low-dose injection Stabilizes levels quickly
Earlier reinsertion Reduces duration of symptoms

Waiting for the next scheduled insertion without intervention often prolongs symptoms unnecessarily.


Can the crash be prevented while staying on pellets?

There are ways to reduce the severity of the crash, but not eliminate it.

Strategy Effect
Shorter reinsertion schedule Reduces time in low phase
Lab-based timing Improves precision
Bridge therapy Fills hormone gap
Higher pellet dose Extends duration but increases peak risk

These approaches improve the experience but do not change the underlying release pattern.


When it makes sense to consider alternatives

If your cycle consistently follows this pattern:

    • stable period
    • decline
    • symptom return
    • repeat

then the issue may be the delivery method rather than the dose.

Alternative therapies such as injections or transdermal applications allow for dose adjustments based on labs and symptoms.

This often results in more stable hormone levels over time.

The
NAMS hormone therapy position statement
supports individualized hormone therapy approaches based on symptom response and risk profile.

For more details, see this
👉 BioTE alternative guide


Questions to ask your provider

If you plan to continue pellet therapy, it helps to review your data.

Ask about:

    • hormone levels during peak phase
    • hormone levels during trough phase
    • how timing is adjusted based on labs
    • what options exist if symptoms return early

This information allows for more individualized care.


A practical way to think about pellet therapy

Pellet therapy offers convenience and long dosing intervals.

However, it follows a fixed release curve that cannot be adjusted after insertion.

Patients whose bodies align with that curve may do well.

Others may experience peaks and troughs that are difficult to manage.

Understanding your pattern helps determine whether to adjust timing or consider a different approach.


Where Amazing Meds fits in

Amazing Meds helps patients:

    • confirm pellet depletion through labs
    • provide short-term stabilization options
    • adjust timing based on data
    • transition to more flexible therapies when needed

The goal is not just to continue treatment, but to make it work consistently.

👉 See if you qualify


FAQ

Is a pellet crash normal?

It is common and reflects how pellet therapy works, but it should still be managed.

Can labs confirm a pellet crash?

Yes. Hormone levels typically show a decline into the low range.

Do all patients experience this?

No. Timing and severity vary by individual.

Should I switch therapy?

It depends on how consistently symptoms return.

Should I stop therapy during a crash?

No. Stabilizing hormone levels is the better approach.